The Medicines (Products for Human Use) (Fees) Regulations 2016

Suspension of licences and authorisationsU.K.

This section has no associated Explanatory Memorandum

58.—(1) Where any sum due by way of, or on account of, any fee or any part of a fee payable under these Regulations remains unpaid by—

(a)the holder of a product licence or a product licence of right;

(b)the holder of a manufacturer's licence;

(c)the holder of a manufacturer's authorisation;

(d)the holder of a wholesale dealer's licence; or

(e)a person included on the list of online sellers of medicines,

the licensing authority may serve a written notice on the holder requiring payment of the sum unpaid.

(2) If after a period of one month commencing on the date of service of the notice referred to in paragraph (1), or such longer period as the licensing authority may allow, the said sum remains unpaid, the licensing authority may forthwith suspend the licence, authorisation or entry on the list of online sellers of medicines, as the case may be, until such sum has been paid.